Dentsu Health Appoints Amanda Lawson and Bruce Rinderman as Media and Creative Strategy Leaders
Industry Veterans Join Dentsu Health to Elevate Patient Experience Through Personalization and Human-Centered Storytelling
New York, NY – February 9, 2022 – Dentsu Health today announced the appointment of healthcare marketing industry veteran Amanda Lawson, as SVP, Global Head of Media, and Bruce Rinderman, as Head of Brand Planning and Creative Strategy. Launched in April 2021, dentsu health has been actively bringing together top talent from the healthcare marketing industry to help brands create a more equitable health ecosystem, focused on the overall consumer wellness and personalized experience for patients and HCPs.
Lawson has a successful track record working with and leading some of the largest pharma clients, including Novartis, AstraZeneca, Novo Nordisk, Sanofi, HCA, Daiichi Sankyo, and EMD Serono. In her new role at dentsu health, she will focus on leading and expanding a media capability that drives transformation, agility, and creativity.
“Amanda has dedicated her entire career to this industry. I had the fortune of working with her for many of those years. She is a true leader, has a lot of experience in building and scaling teams across agencies, and inspiring clients to evolve their approach to media.” said Greg Reilly, EVP, Global Clients at dentsu health. “Our clients are demanding more integrated solutions, efficiency, and flexibility - solving bigger problems with fewer agency partners. We set out to address that exact need, with capabilities and expertise across media, creative and customer experience, delivered by a tight-knit team that is closest to the pulse of the industry. Amanda will be a tremendous asset to our clients and the broader dentsu health team.”
Prior to dentsu, Amanda was SVP of Publicis Health Media, where she oversaw one of the largest pharmaceutical manufacturers in the US, supporting their Patient and HCP business across all media channels. She led 175+ employees across multiple agencies and cross-functional capabilities to deliver best-in-class media strategy, buying, and campaign management. Amanda started her career in media planning at Digitas Health before joining PHM.
Along with the appointment of Amanda and dentsu health’s Chief Creative Officer Collette Douaihy, Bruce Rinderman also joins the dentsu health team to head up brand planning and creative strategy, leveraging his experience and expertise from Merkle B2B, a dentsu company.
“I’m thrilled to have Bruce join the team and am confident he will make a significant impact,” said Collette Douaihy, Chief Creative Officer. “Creative strategy is key to producing great work, and there’s no better partner than Bruce, who brings a wealth of experience that will be of great value to our clients, our people, and our agency brands.”
Bruce has dedicated his decades-long career to healthcare marketing, from blockbusters to rare and orphan drugs across a wide range of categories, including neuroscience, oncology, pain and inflammation, sexual health, urology, cardiology, gastroenterology and endocrinology. He has been a proud creative and strategic partner to pharma big and small, including Pfizer, Eli Lilly, Janssen, Roche, BMS, among others. Prior to Merkle B2B, Bruce was VP, Creative Director at Razorfish Health.
About dentsu health
Dentsu health is transforming the healthcare agency services model through a global teaming platform of 2,000+ experts. Across our global agency brands, specialist agencies and open ecosystem of external partners, we specialize in health, wellness and pharmaceutical marketing.
Dentsu health unites leadership in data and technology with a deep understanding of the emotional territory of healthcare. We equip brands to connect with the right audience at the right moment, but always with ideas that speak to the heart.
Jennifer Ferguson, Chief Communications Officer, dentsu Americas